Recent Data on Axi-Cel in Lymphoma
Dr Leslie discusses two abstracts on axi-cel recently presented at ASH 2023: a subgroup analysis of ZUMA-7 and the 4-year follow-up from ZUMA-5.
Source: onclive.com
Stay updated with breaking news from Indolent Lymphomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr Leslie discusses two abstracts on axi-cel recently presented at ASH 2023: a subgroup analysis of ZUMA-7 and the 4-year follow-up from ZUMA-5.